Course of postoperative relapse in non-small cell lung cancer is strongly associated with post-progression survival,Thoracic Cancer

当前位置： X-MOL 学术 › Thorac. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Course of postoperative relapse in non-small cell lung cancer is strongly associated with post-progression survival
Thoracic Cancer ( IF 2.3 ) Pub Date : 2021-09-03 , DOI: 10.1111/1759-7714.14119
Hisao Imai _{1,

2} , Ryoichi Onozato ₃ , Kyoichi Kaira ₂ , Sayaka Kawashima ₄ , Ken Masubuchi ₁ , Toshiteru Nagashima ₃ , Kohei Tajima ₃ , Koichi Minato ₁

Affiliation

For early-stage non-small cell lung cancer (NSCLC), surgical resection is considered the most effective treatment strategy and curative treatment. Unfortunately, even after complete resection, almost half of all patients with stage I–IIIA NSCLC relapse and die. Although the possibility of a cure for postoperative recurrence of NSCLC is significantly low, the course of subsequent treatment can possibly affect overall survival (OS). Here, we examined the association of relapse-free survival (RFS) and post-progression survival (PPS) with OS in patients with postoperative recurrence of NSCLC.

中文翻译：

非小细胞肺癌术后复发过程与进展后生存率密切相关

对于早期非小细胞肺癌（NSCLC），手术切除被认为是最有效的治疗策略和根治性治疗。不幸的是，即使在完全切除后，几乎一半的 I-IIIA 期 NSCLC 患者复发并死亡。尽管 NSCLC 术后复发治愈的可能性非常低，但后续治疗过程可能会影响总生存期 (OS)。在这里，我们检查了 NSCLC 术后复发患者的无复发生存期 (RFS) 和进展后生存期 (PPS) 与 OS 的关系。

更新日期：2021-10-18

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11